Ludwig Maximilian University of Munich-ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2019

  1. Nanobiotechnology in parkinson’s disease

    Nanobiotechnology in Neurodegenerative Diseases (Springer International Publishing), pp. 177-208

2018

  1. Novel PAMAM-PEG-peptide conjugates for siRNA delivery targeted to the transferrin and epidermal growth factor receptors

    Journal of Personalized Medicine, Vol. 8, Núm. 1

2015

  1. Evaluation of improved PAMAM-G5 conjugates for gene delivery targeted to the transferrin receptor

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 94, pp. 116-122

2010

  1. Low generation PAMAM dendrimer and CpG free plasmids allow targeted and extended transgene expression in tumors after systemic delivery

    Journal of Controlled Release, Vol. 146, Núm. 1, pp. 99-105